{
    "nctId": "NCT02653105",
    "briefTitle": "Women at Risk of Breast Cancer and OLFM4",
    "officialTitle": "Evaluation of the Circulating Concentration of Olfactom\u00e9dine 4 (OLFM4) in Women With a BRCA1 or 2 Gene Mutation or at High Risk of Developing Breast Cancer, According to the Imaging",
    "overallStatus": "RECRUITING",
    "conditions": "Hereditary Breast and Ovarian Cancer Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "The OLFM4 rate will be dosing by ELISA test in initial and followed blood sample of patient. This rate will be compared to the imaging to determine the positive predictive value of the assay OLFM4",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\> or = 18 years\n* High risk women of breast cancer occurrence defined by the following criteria:\n\n  * Women carrying a genetic mutation BRCA1 or 2 or TP53, entering or already in screening breast IRM\n  * Women with a high probability of hereditary predisposition to breast cancer (20% risk at 70 years of breast cancer by BOADICEA model), assessed by the onco-geneticists\n* Information of the person and signing the informed consent\n\nExclusion Criteria:\n\n* Women with a history of breast cancer or in situ\n* Person who is not affiliated to a social security scheme or beneficiary of such a regime",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}